Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Shovlin

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Orphanet Journal of Rare Diseases|August 30, 2019
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasiaC L Shovlin, C M Millar, F Droege, et al.
European Journal of Medical Genetics|November 5, 2021
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality careC L Shovlin, E Buscarini, C Sabbà, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Orphanet Journal of Rare Diseases|August 30, 2019
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasiaC L Shovlin, C M Millar, F Droege, et al.
European Journal of Medical Genetics|November 5, 2021
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality careC L Shovlin, E Buscarini, C Sabbà, et al.
Pageof 4